PIS
BMY icon

POM Investment Strategies’s Bristol-Myers Squibb BMY Stock Holding History

POM Investment Strategies’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.6K Sell
513
-520
-50% -$29.9K 0.03% 117
2026
Q1 		$62.7K Buy
1,033
+120
+13% +$7K 0.08% 98
2025
Q4 		$49.3K Buy
+913
New +$43.9K 0.03% 66

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

POM Investment Strategies's BMY Position: Q2 2026 in Review

POM Investment Strategies reduced its Bristol-Myers Squibb (BMY) stake by 50% in Q2 2026, selling an estimated $29.9K and leaving 513 shares worth $29.6K. The position accounts for 0.03% of the portfolio, ranked #117.

POM Investment Strategies first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $62.7K in Q1 2026. 1,182 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • POM Investment Strategies held 513 shares of Bristol-Myers Squibb worth $29.6K as of Q2 2026.
  • POM Investment Strategies sold 520 Bristol-Myers Squibb shares in Q2 2026, an estimated $29.9K.
  • Bristol-Myers Squibb made up 0.03% of POM Investment Strategies's portfolio in Q2 2026, its #117 holding.
  • POM Investment Strategies first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • POM Investment Strategies's Bristol-Myers Squibb position peaked at $62.7K in Q1 2026.
  • 1,182 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.